| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1748* | 2021 |
| Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort DT Arnold, FW Hamilton, A Milne, AJ Morley, J Viner, M Attwood, A Noel, ... Thorax 76 (4), 399-401, 2021 | 675 | 2021 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 476 | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 441* | 2021 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 317 | 2021 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 286 | 2022 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 233 | 2022 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 219 | 2022 |
| Comparison of direct and indirect methods of estimating health state utilities for resource allocation: review and empirical analysis D Arnold, A Girling, A Stevens, R Lilford Bmj 339, 2009 | 192 | 2009 |
| Investigating unilateral pleural effusions: the role of cytology DT Arnold, D De Fonseka, S Perry, A Morley, JE Harvey, A Medford, ... European Respiratory Journal 52 (5), 2018 | 162 | 2018 |
| The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular … E Avolio, M Carrabba, R Milligan, M Kavanagh Williamson, AP Beltrami, ... Clinical Science 135 (24), 2667-2689, 2021 | 142 | 2021 |
| Nonmalignant pleural effusions: a prospective study of 356 consecutive unselected patients SP Walker, AJ Morley, L Stadon, D De Fonseka, DT Arnold, ARL Medford, ... Chest 151 (5), 1099-1105, 2017 | 112 | 2017 |
| Are vaccines safe in patients with Long COVID? A prospective observational study DT Arnold, A Milne, E Samms, L Stadon, NA Maskell, FW Hamilton Medrxiv, 2021.03. 11.21253225, 2021 | 81 | 2021 |
| Birmingham and Lambeth Liver Evaluation Testing Strategies (BALLETS): a prospective cohort study. RJ Lilford, L Bentham, A Girling, I Litchfield, R Lancashire, D Armstrong, ... Health technology assessment (Winchester, England) 17 (28), i-xiv, 1, 2013 | 81 | 2013 |
| Physical, cognitive and mental health impacts of COVID-19 following hospitalisation–a multi-centre prospective cohort study RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... MedRxiv, 2021 | 80 | 2021 |
| Symptoms after COVID-19 vaccination in patients with persistent symptoms after acute infection: a case series DT Arnold, A Milne, E Samms, L Stadon, NA Maskell, FW Hamilton Annals of Internal Medicine 174 (9), 1334-1336, 2021 | 69 | 2021 |
| Early Warning Scores do not accurately predict mortality in sepsis: A meta-analysis and systematic review of the literature F Hamilton, D Arnold, A Baird, M Albur, P Whiting Journal of Infection 76 (3), 241-248, 2018 | 64 | 2018 |
| Differential T-cell reactivity to endemic coronaviruses and SARS-CoV-2 in community and health care workers R da Silva Antunes, S Pallikkuth, E Williams, E Dawen Yu, J Mateus, ... The Journal of infectious diseases 224 (1), 70-80, 2021 | 62 | 2021 |
| SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination F Liew, S Talwar, A Cross, BJ Willett, S Scott, N Logan, MK Siggins, ... EBioMedicine 87, 2023 | 59 | 2023 |
| Aerosol generating procedures: are they of relevance for transmission of SARS-CoV-2? F Hamilton, D Arnold, BR Bzdek, J Dodd, C White, J Murray, J Keller, ... The Lancet Respiratory Medicine 9 (7), 687-689, 2021 | 57 | 2021 |
